<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> (PSC) is an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> of the hepatobiliary system for which effective therapy has not been established </plain></SENT>
<SENT sid="1" pm="."><plain>Leukocytapheresis (LCAP) therapy is known to effective in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, effects of LCAP therapy were reported on some <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> such as <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> and <z:hpo ids='HP_0003678'>rapidly progressive</z:hpo> <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report the case of a 29-year-old man with PSC associated with UC who was treated with LCAP therapy </plain></SENT>
<SENT sid="4" pm="."><plain>He had a 16-year history of UC and a 12-year history of PSC </plain></SENT>
<SENT sid="5" pm="."><plain>Although he was under treatment with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="1" ids="9907">ursodeoxycholic acid</z:chebi>, exacerbation of UC and PSC-associated <z:hpo ids='HP_0001396'>cholestasis</z:hpo> were seen </plain></SENT>
<SENT sid="6" pm="."><plain>Since he showed side effects of <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, he was treated with LCAP </plain></SENT>
<SENT sid="7" pm="."><plain>Not only improvement of UC, but also <z:hpo ids='HP_0003282'>decreased serum alkaline phosphatase</z:hpo>, gamma-<z:chebi fb="0" ids="15996">guanosine triphosphate</z:chebi> and total <z:chebi fb="1" ids="3098">bile acids</z:chebi>, suggesting improvement of PSC-associated cholestaisis, were seen after treatment with LCAP </plain></SENT>
<SENT sid="8" pm="."><plain>Our experience with this case suggests that LCAP therapy could be a new effective therapeutic strategy for patients with PSC associated with UC </plain></SENT>
</text></document>